SCHEMBL7826425

SCHEMBL7826425

CCC(O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)C(C)=Cc1cccnc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.40
CYP19A1 P11511 1/20 0.40
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP11B1 P15538 1/20 0.35
RAB9A P51151 3/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
TBXAS1 P24557 3/20 0.34
ALOX5 P09917 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
HSP90AA1 P07900 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4190490 0.89 CYP11B2 (0.39) CYP11B2CYP19A1MAPTLMNASMN1; SMN2
SCHEMBL4190495 0.89 CYP11B2 (0.39) CYP11B2CYP19A1MAPTLMNASMN1; SMN2
SCHEMBL4197083 0.88 CYP11B2 (0.38) CYP11B2CYP19A1MAPTLMNASMN1; SMN2
SCHEMBL4197077 0.88 CYP11B2 (0.38) CYP11B2CYP19A1MAPTLMNASMN1; SMN2
SCHEMBL7823603 0.87 CYP19A1 (0.36) CYP11B2CYP19A1LMNASMN1; SMN2GAA
Iodide SCHEMBL4355036 0.85 CYP11B2 (0.36) CYP11B2CYP19A1MAPTLMNASMN1; SMN2
Iodide SCHEMBL4355033 0.85 CYP11B2 (0.36) CYP11B2CYP19A1MAPTLMNASMN1; SMN2
Iodide SCHEMBL4355027 0.85 CYP11B2 (0.36) CYP11B2CYP19A1MAPTLMNASMN1; SMN2
Iodide SCHEMBL4355025 0.85 CYP11B2 (0.36) CYP11B2CYP19A1MAPTLMNASMN1; SMN2
SCHEMBL4192151 0.84 CYP11B2 (0.35) CYP11B2CYP19A1MAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161430-A2 EPOTHILON DERIVATIVES, METHOD FOR THE PRODUCTION AND THE USE THEREOF AS PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2001-12-12 EP disclosed
WO-2000047584-A2 EPOTHILON DERIVATIVES, METHOD FOR THE PRODUCTION AND THE USE THEREOF AS PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-08-17 WO disclosed